Skip to main content

Breadcrumb

  1. Home

The Society of Thoracic Surgeons

Anti-Lipid Treatment Discharge

  • Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on a lipid lowering statin

    CBE ID
    0118

Anti-platelet medication on discharge

  • Number of procedures for which the patient was discharged from the facility on Aspirin, enteric coated aspirin, or ADP Inhibitors/ Number of Isolated CABG procedures excluding those that resulted in in-hospital mortalities based on the variables Mortality Discharge Status, Mortality Date, and Discharge Date

    CBE ID
    0237

Beta Blockade at Discharge

  • Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on beta blockers

    CBE ID
    0117

Beta blocker on discharge

  • Number of procedures for which the patient was discharged from the facility on beta blockers/ Number of Isolated CABG procedures excluding those that resulted in in-hospital mortalities based on the variables Mortality Discharge Status, Mortality Date, and Discharge Date

    CBE ID
    0238

Operative Mortality Stratified by the 5 STAT Mortality Categories

  • Percent of patients undergoing index pediatric and/or congenital heart surgery who die, including both 1) all deaths occurring during the hospitalization in which the procedure was performed, even if after 30 days (including patients transferred to other acute care facilities), and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure, stratified by the five STAT Mortality Categories, a multi-institutional validated risk stratification tool

    CBE ID
    0733